109 related articles for article (PubMed ID: 1706915)
1. Differential effects of sodium butyrate and hexamethylene bisacetamide on growth and secretion of cultured human endocrine tumor cells.
Parekh D; Ishizuka J; Townsend CM; Haber BE; Beauchamp RD; Rajaraman S; Karp G; Hsieh J; Thompson JC
Arch Surg; 1991 Apr; 126(4):467-72. PubMed ID: 1706915
[TBL] [Abstract][Full Text] [Related]
2. Induction of phenotypic changes in SCLC cell lines in vitro by hexamethylene bisacetamide, sodium butyrate, and cyclic AMP.
Khan MZ; Freshney RI; McNicol AM; Murray AM
Ann Oncol; 1993 Jun; 4(6):499-507. PubMed ID: 8394737
[TBL] [Abstract][Full Text] [Related]
3. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
4. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
Ishizuka J; Beauchamp RD; Sato K; Townsend CM; Thompson JC
J Cell Physiol; 1993 Jul; 156(1):112-8. PubMed ID: 8391003
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
[TBL] [Abstract][Full Text] [Related]
6. Effect of 5-HT3 receptor antagonist (ondansetron) on functioning human pancreatic carcinoid cells.
Ishizuka J; Hsieh AC; Townsend CM; Thompson JC
Surg Oncol; 1993 Aug; 2(4):221-5. PubMed ID: 8252212
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion.
Parekh D; Ishizuka J; Townsend CM; Haber B; Beauchamp RD; Karp G; Kim SW; Rajaraman S; Greeley G; Thompson JC
Pancreas; 1994 Jan; 9(1):83-90. PubMed ID: 8108375
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents.
Goto I; Yamamoto-Yamaguchi Y; Honma Y
Br J Cancer; 1996 Aug; 74(4):546-54. PubMed ID: 8761368
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines.
Mullins TD; Kern HF; Metzgar RS
Pancreas; 1991 Sep; 6(5):578-87. PubMed ID: 1946315
[TBL] [Abstract][Full Text] [Related]
10. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
11. Effect of AML serum on normal human myeloid differentiation and hexamethylene bisacetamide-induced granulocytic differentiation of the human HL-60 promyelocytic leukaemic cell line.
Hassan HT; Rees JK
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):151-9. PubMed ID: 1695170
[TBL] [Abstract][Full Text] [Related]
12. Studies of growth regulation in a neuroendocrine cell line.
Townsend CM; Ishizuka J; Thompson JC
Acta Oncol; 1993; 32(2):125-30. PubMed ID: 8323753
[TBL] [Abstract][Full Text] [Related]
13. Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube.
Ward FT; Kelley JA; Roth JS; Lombardo FA; Weiss RB; Leyland-Jones B; Chun HG
Cancer Res; 1991 Apr; 51(7):1803-10. PubMed ID: 2004365
[TBL] [Abstract][Full Text] [Related]
14. Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell lines.
McIntyre LJ; Kim YS
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):265-71. PubMed ID: 6200329
[TBL] [Abstract][Full Text] [Related]
15. [Effect of hexamethylene bisacetamide on human gastric cancer cell line SGC-7901].
Xu SW
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):30-3. PubMed ID: 2194772
[TBL] [Abstract][Full Text] [Related]
16. Melatonin and its precursors in Y79 human retinoblastoma cells: effect of sodium butyrate.
Deng MH; Lopez G-Coviella I; Lynch HJ; Wurtman RJ
Brain Res; 1991 Oct; 561(2):274-8. PubMed ID: 1802344
[TBL] [Abstract][Full Text] [Related]
17. Activin A inhibits growth and hexamethylene bisacetamide-induced differentiation in human retinoblastoma Y-79 cells.
Zhang Z; Batres Y; Ying SY
Anticancer Res; 1996; 16(1):269-72. PubMed ID: 8615619
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth.
Evers BM; Townsend CM; Upp JR; Allen E; Hurlbut SC; Kim SW; Rajaraman S; Singh P; Reubi JC; Thompson JC
Gastroenterology; 1991 Aug; 101(2):303-11. PubMed ID: 1712329
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C).
Gerharz CD; Gabbert HE; Engers R; Ramp U; Mayer H; Luley C
Br J Cancer; 1989 Oct; 60(4):578-84. PubMed ID: 2803927
[TBL] [Abstract][Full Text] [Related]
20. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells.
Guilbaud NF; Gas N; Dupont MA; Valette A
J Cell Physiol; 1990 Oct; 145(1):162-72. PubMed ID: 2211839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
